CT1194D
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CT1194D, covering 2025-10-01 to 2025-10-01. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms [Phase 1]